Augmentin has been recognised as the 1st runner-up in the Brand of the Year - Acute, above Rs 2,000 crore category - at the AWACS Marketing Excellence Awards 2022
Our new #GSK logo embodies our purpose and provides a powerful symbol to represent our brand. It has been designed with some key details that amplify our #brand personality and express our drive, focus and precision.
The construction of our logo includes some key elements which not only act to simplify our brand personality but to indicate the level of focus, drive and precision that our brand embodies.Click here to know more
Our 6-in-1 awareness programme MS Dhoni teams up with GSK to create awareness for parents and their babies to hit a 6!Click here to know more
GSK Scholars Programme Our new CSR initiative which aims to support talented albeit financially constrained MBBS students and drive India’s skill-building and STEM education goals.Click here to know more
Press Release, 11th November, 2022 GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended September 30, 2022Click here to read more
Media GSK launches Trelegy Ellipta – a once daily, single-inhaler triple therapy for COPD patients for the first time in IndiaClick here to read more
Research and development Trust in Science
In India, we have partnered the Regional Centre for Biotechnology (established by the Department of Biotechnology, Ministry of Science and Technology, Government of India) for fostering scientific and technological co-operation while supporting biostatisticians and bio-informatics professionals.Read more
Find out more
Who we are
We are driven by our purpose to help people do more, feel better and live longer. Find out more about who we are, what we do and how we do it.
Our corporate social responsibility
We are ‘Partnering India to Eliminate Lymphatic Filariasis’. Find out more about our CSR initiatives.
Explore our products
Explore our broad range of medicines and vaccines that benefit patients across the country.